Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Self-adjuvanting cancer nanovaccines

Fig. 4

Copyright 2019 Ivyspring International Publisher

3DSNA nanovaccine activated the innate and specific immunity by the NF-κB signaling pathway. A Schematic of 3DSNA as versatile adjuvants that initiate antigen-specific CTL responses for cancer immunotherapy. B The analysis of p-p65 by laser scanning confocal microscopy. C The survival of tumor-bearing mice treated with different formulations after tumor challenge. Reproduced with permission [71].

Back to article page